Paul C. Watkins

Mr. Watkins has over 20 years of experience in biotechnology, life science, genomics and pharmaceutical companies. Prior to BioMarker, he was responsible for business development, scientific affairs, new product identification and intellectual property strategy and portfolio management at Ancile Pharmaceuticals, Inc. Mr. Watkins held senior management positions in business and corporate development at Axys Pharmaceuticals (formerly Sequana Therapeutics) specializing in licensing, technology transfer, strategic alliances and joint ventures. Mr. Watkins directed R&D groups in molecular genetics while at Life Technologies Inc. and Integrated Genetics Inc. He has been awarded an issued U.S. patent and is an author on over 80 international scientific publications. Mr. Watkins obtained his B.S. in Microbiology & Public Health at Michigan State University and his S.M. in Interdisciplinary Sciences at the Massachusetts Institute of Technology.